FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1222331000168100: Lyxumia (lixisenatide 20 microgram / 0.2 mL) injection, 3 mL pen device (trade product unit of use)

Status: current, Defined. Date: 30-Nov 2018. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3173571000168112 Lyxumia (lixisenatide 20 microgram / 0.2 mL) injection, 3 mL pen device (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3173581000168110 Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Is a lixisenatide 20 microgram/0.2 mL injection, 3 mL pen device true Inferred relationship Some
Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Is a Lyxumia true Inferred relationship Some
Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Is a trade product unit of use true Inferred relationship Some
Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device has manufactured dose form injection true Inferred relationship Some
Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device has unit of use pen device true Inferred relationship Some 1279489785
Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device has Australian BoSS lixisenatide true Inferred relationship Some 1279489784
Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device has intended active ingredient lixisenatide true Inferred relationship Some 1279489784
Inbound Relationships Type Active Source Characteristic Refinability Group
Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device has TPUU True Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Inferred relationship Some 1
Lyxumia 20 microgram/0.2 mL injection, 2 x 3 mL pen devices has TPUU True Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Inferred relationship Some 1
Lyxumia 20 microgram/0.2 mL injection, 2 x 3 mL pen devices has TPUU True Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Inferred relationship Some 1
Lyxumia 20 microgram/0.2 mL injection, 6 x 3 mL pen devices has TPUU True Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Inferred relationship Some 1
Lyxumia 20 microgram/0.2 mL injection, 6 x 3 mL pen devices has TPUU True Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Inferred relationship Some 1
Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device has TPUU True Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Inferred relationship Some 1
Lyxumia Treatment Initiation Pack (1 x 10 microgram/0.2 mL (3 mL) pen device, 1 x 20 microgram/0.2 mL (3 mL) pen device), 1 pack has TPUU True Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Inferred relationship Some 1
Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) has TPUU True Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Inferred relationship Some 1
Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack has TPUU True Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Inferred relationship Some 2
Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack has TPUU True Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start